Nucleus of Meynert Cholinergic Neurons

Nucleus of Meynert Cholinergic Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Nucleus of Meynert Cholinergic Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000108](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000108](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:2000056](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_2000056)</td>
</tr>
<tr>
<td class="label">Subregion</td>
<td>Abbreviation</td>
</tr>
<tr>
<td class="label">Ch1 - Septal diagonal band</td>
<td>DB</td>
</tr>
<tr>
<td class="label">Ch2 - Horizontal limb</td>
<td>HDB</td>
</tr>
<tr>
<td class="label">Ch4 - Nucleus basalis</td>
<td>NB</td>
</tr>
<tr>
<td class="label">Ch4p - Posterior part</td>
<td>Ch4p</td>
</tr>
<tr>
<td class="label">Source</td>
<td>Pathway</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Septohippocampal loop</td>
</tr>
<tr>
<td class="label">Brainstem raphe</td>
<td>Serotonergic input</td>
</tr>
<tr>
<td class="label">Brainstem locus

Nucleus of Meynert Cholinergic Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Nucleus of Meynert Cholinergic Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000108](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000108](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:2000056](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_2000056)</td>
</tr>
<tr>
<td class="label">Subregion</td>
<td>Abbreviation</td>
</tr>
<tr>
<td class="label">Ch1 - Septal diagonal band</td>
<td>DB</td>
</tr>
<tr>
<td class="label">Ch2 - Horizontal limb</td>
<td>HDB</td>
</tr>
<tr>
<td class="label">Ch4 - Nucleus basalis</td>
<td>NB</td>
</tr>
<tr>
<td class="label">Ch4p - Posterior part</td>
<td>Ch4p</td>
</tr>
<tr>
<td class="label">Source</td>
<td>Pathway</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Septohippocampal loop</td>
</tr>
<tr>
<td class="label">Brainstem raphe</td>
<td>Serotonergic input</td>
</tr>
<tr>
<td class="label">Brainstem locus coeruleus</td>
<td>Noradrenergic input</td>
</tr>
<tr>
<td class="label">Hypothalamus</td>
<td>Orexin/hypocretin</td>
</tr>
<tr>
<td class="label">Amygdala</td>
<td>Basolateral</td>
</tr>
<tr>
<td class="label">Target Region</td>
<td>Projection Type</td>
</tr>
<tr>
<td class="label">Frontal Cortex</td>
<td>Dense</td>
</tr>
<tr>
<td class="label">Parietal Cortex</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Temporal Cortex</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Occipital Cortex</td>
<td>Sparse</td>
</tr>
<tr>
<td class="label">Effect</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Desynchronization</td>
<td>Inhibits GABAergic interneurons</td>
</tr>
<tr>
<td class="label">Enhanced plasticity</td>
<td>Activate muscarinic receptors</td>
</tr>
<tr>
<td class="label">Increased blood flow</td>
<td>Vasodilation via NO</td>
</tr>
<tr>
<td class="label">Attention enhancement</td>
<td>Reduce background activity</td>
</tr>
<tr>
<td class="label">Stage</td>
<td>NBM Involvement</td>
</tr>
<tr>
<td class="label">Preclinical</td>
<td>Minimal loss</td>
</tr>
<tr>
<td class="label">MCI</td>
<td>30-50% loss</td>
</tr>
<tr>
<td class="label">Mild AD</td>
<td>50-70% loss</td>
</tr>
<tr>
<td class="label">Moderate AD</td>
<td>70-85% loss</td>
</tr>
<tr>
<td class="label">Severe AD</td>
<td>>90% loss</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Donepezil</td>
<td>Reversible AChE inhibitor</td>
</tr>
<tr>
<td class="label">Rivastigmine</td>
<td>Pseudo-irreversible AChE</td>
</tr>
<tr>
<td class="label">Galantamine</td>
<td>Allosteric AChE modulator</td>
</tr>
<tr>
<td class="label">Technique</td>
<td>Information Provided</td>
</tr>
<tr>
<td class="label">ChAT immunohistochemistry</td>
<td>Cholinergic neuron localization</td>
</tr>
<tr>
<td class="label">Retrograde tracing</td>
<td>Connectivity mapping</td>
</tr>
<tr>
<td class="label">Electrophysiology</td>
<td>Firing patterns, properties</td>
</tr>
<tr>
<td class="label">Optogenetics</td>
<td>Circuit function</td>
</tr>
<tr>
<td class="label">Calcium imaging</td>
<td>Activity patterns in vivo</td>
</tr>
</table>

Introduction

The Nucleus of Meynert (NBM), also known as the Nucleus Basalis of Meynert, is a prominent group of cholinergic neurons located in the basal forebrain that provides the primary cholinergic innervation to the cerebral cortex [1](https://pubmed.ncbi.nlm.nih.gov/28806525/). These neurons are critical for cognitive function, particularly attention, memory, and arousal, and are prominently affected in Alzheimer's disease (AD) and other neurodegenerative disorders. [@mesulam2013]

The NBM was first described by Theodor Meynert in 1872 as a large collection of neurons in the basal forebrain projecting to the cortex. It has since become a central focus of neurodegenerative research due to its critical role in cholinergic signaling and its degeneration in AD. [@hasselmo1995]

<!-- taxonomy-enrichment --> [@ballinger2016]

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: cholinergic neuron (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000108)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)
• [OBO Foundry (CL:0000108)](http://purl.obolibrary.org/obo/CL_0000108)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000108)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)
• [OBO Foundry (CL:0000108)](http://purl.obolibrary.org/obo/CL_0000108)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Anatomical Location and Organization

Spatial Distribution

The NBM is located in the basal forebrain, specifically:

• Medial position: Situated between the diagonal band of Broca and the ansa peduncularis
• Anterior-posterior extent: Spans from the posterior part of the septal area to the level of the anterior commissure
• Rostral: Near the horizontal limb of the diagonal band
• Caudal: Extends into the substantia innominata

Subdivisions

The NBM can be divided into several subregions:

Cellular Characteristics

• Cell type: Large, polymorphic neurons (20-50 μm soma diameter)
• Neurotransmitter: Acetylcholine (ACh)
• Markers: Choline acetyltransferase (ChAT), Nerve growth factor (NGF), TrkA receptor
• Morphology: Multipolar neurons with extensive dendritic arborization

Connectivity

Afferent Inputs (Inputs to NBM)

The NBM receives input from several brain regions:

Efferent Outputs (Outputs from NBM)

The NBM projects extensively to the cortex:

• Widespread cortical projections: To all cortical areas
• Topographic organization: Specific NBM regions project to specific cortical areas
• Mode of transmission: Primarily via cholinergic varicosities

Electrophysiology

Firing Patterns

NBM cholinergic neurons exhibit distinct electrophysiological properties:

Response Properties

• Stimulus-responsive: Activated by salient sensory stimuli
• Reward-related: Fire during reward expectation and receipt
• Novelty-detecting: Respond to novel stimuli
• Memory-linked: Activity correlates with memory encoding

Ion Channel Properties

• Depolarizing currents: Sustained sodium currents
• Hyperpolarization: HCN (hyperpolarization-activated cyclic nucleotide-gated) channels
• Calcium dynamics: T-type and L-type calcium channels

Function in Normal Brain

Cognitive Functions

The NBM cholinergic system supports several critical cognitive functions:

Neuromodulatory Effects

Acetylcholine released from NBM terminals produces:

Role in Alzheimer's Disease

Neurodegeneration Pattern

The NBM undergoes severe degeneration in AD:

• Neuron loss: 60-90% loss in advanced AD
• Atrophy: Significant shrinkage visible on MRI
• Tau pathology: Neurofibrillary tangles in surviving neurons
• Amyloid: Amyloid plaques in vicinity

Temporal Progression

Mechanisms of Degeneration

Several interconnected mechanisms contribute to NBM vulnerability:

Cholinergic Hypothesis

The cholinergic hypothesis of AD proposes:

• NBM degeneration leads to cortical ACh deficiency
• Loss of cholinergic modulation contributes to cognitive deficits
• This provides rationale for cholinesterase inhibitor therapy

Role in Other Neurodegenerative Diseases

Parkinson's Disease with Dementia (PDD)

• Significant NBM loss in PDD patients
• Correlates with attentional and executive deficits
• Lewy bodies can be found in NBM neurons
• Cholinergic dysfunction contributes to gait and postural deficits

Dementia with Lewy Bodies (DLB)

• Severe NBM degeneration similar to AD
• Cholinergic deficits may be more severe than AD
• Contributes to visual hallucinations and attention deficits

Progressive Supranuclear Palsy (PSP)

• Moderate NBM involvement
• Contributes to cognitive impairment
• Often less severe than in AD

Corticobasal Degeneration (CBD)

• Variable NBM involvement
• Contributes to cortical dysfunction
• May be asymmetric

Diagnostic Significance

MRI Biomarkers

• Basal forebrain atrophy: On structural MRI
• Cholinergic tract degeneration: Using diffusion tensor imaging
• Correlation: Atrophy correlates with cognitive scores

PET Imaging

• Cholinergic PET ligands: Under development
• Metabolic changes: Reduced cortical metabolism in affected regions

CSF Biomarkers

• Choline acetyltransferase activity: Reduced in CSF
• Neurofilament light: Correlates with degeneration

Therapeutic Implications

Current Treatments

Cholinesterase inhibitors provide symptomatic benefit:

Experimental Approaches

Future Directions

• Neuroprotective strategies: Prevent NBM degeneration
• Combination therapies: AChE inhibitors + disease-modifying agents
• Personalized approaches: Genotype-guided treatment selection
• Early intervention: Target NBM preservation before significant loss

Research Methods

Experimental Models

• Rodent models: Lesion studies, transgenic AD models
• Non-human primates: Pharmacological and lesion studies
• In vitro: Primary cell cultures, organotypic slices

Measurement Techniques

See Also

• [Basal Forebrain Cholinergic System
• [Alzheimer's Disease Pathogenesis](/diseases/alzheimers-disease)
• [Cholinesterase Inhibitors](/entities/cholinesterase-inhibitors)
• Acetylcholine Signaling
• Parkinson's Disease with Dementia](/brain-regions/basal-forebrain-cholinergic-system

• [Dementia with Lewy Bodies](/diseases/lewy-body-dementia)
• [Tau Pathology](/mechanisms/tau-pathology)

External Links

• [Cell Type Database](https://portal.brain-map.org/)
• [PubMed: Cell Type Markers](https://pubmed.ncbi.nlm.nih.gov/)

Pathway Diagram

The following diagram shows the key molecular relationships involving Nucleus of Meynert Cholinergic Neurons discovered through SciDEX knowledge graph analysis: